“Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective” (2020) Farmeconomia. Health Economics and Therapeutic Pathways, 21(1). doi:10.7175/fe.v21i1.1472.